AAAAAA

   
Results: 1-7 |
Results: 7
Lack of pharmacokinetic interaction between the antimigraine compound, almotriptan, and propranolol in healthy volunteers
Authors: Fleishaker, JC Sisson, TA Carel, BJ Azie, NE
Citation: Jc. Fleishaker et al., Lack of pharmacokinetic interaction between the antimigraine compound, almotriptan, and propranolol in healthy volunteers, CEPHALALGIA, 21(1), 2001, pp. 61-65
Effect of MAO-A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans
Authors: Fleishaker, JC Ryan, KK Jansat, JM Carel, BJ Bell, DJA Burke, MT Azie, NE
Citation: Jc. Fleishaker et al., Effect of MAO-A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans, BR J CL PH, 51(5), 2001, pp. 437-441
Evaluation of the potential pharmacokinetic interaction between almotriptan and fluoxetine in healthy volunteers
Authors: Fleishaker, JC Ryan, KK Carel, BJ Azie, NE
Citation: Jc. Fleishaker et al., Evaluation of the potential pharmacokinetic interaction between almotriptan and fluoxetine in healthy volunteers, J CLIN PHAR, 41(2), 2001, pp. 217-223
Lack of effect of reboxetine on cardiac repolarization
Authors: Fleishaker, JC Francom, SF Herman, BD Knuth, DW Azie, NE
Citation: Jc. Fleishaker et al., Lack of effect of reboxetine on cardiac repolarization, CLIN PHARM, 70(3), 2001, pp. 261-269
Intravenous diltiazem and CYP3A-mediated metabolism
Authors: Masica, AL Azie, NE Brater, DC Hall, SD Jones, DR
Citation: Al. Masica et al., Intravenous diltiazem and CYP3A-mediated metabolism, BR J CL PH, 50(3), 2000, pp. 273-276
Pharmacokinetic interaction between verapamil and almotriptan in healthy volunteers
Authors: Fleishaker, JC Sisson, TA Carel, BJ Azie, NE
Citation: Jc. Fleishaker et al., Pharmacokinetic interaction between verapamil and almotriptan in healthy volunteers, CLIN PHARM, 67(5), 2000, pp. 498-503
Pharmacokinetics and tolerability of a novel 5-HT1D agonist, PNU-142633F
Authors: Fleishaker, JC Pearson, LK Knuth, DW Gomez-Mancilla, B Francom, SF McIntosh, MJ Freestone, S Azie, NE
Citation: Jc. Fleishaker et al., Pharmacokinetics and tolerability of a novel 5-HT1D agonist, PNU-142633F, INT J CL PH, 37(10), 1999, pp. 487-492
Risultati: 1-7 |